Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Melanoma

NCT00003552 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

NIH

Sponsor class

Conditions

Stage IV Melanoma
Recurrent Melanoma

Interventions

DRUG: allogeneic lymphocytes
DRUG: anti-thymocyte globulin
DRUG: cyclophosphamide
DRUG: fludarabine

Sponsor

National Heart, Lung, and Blood Institute (NHLBI)